Philip R. Kuhl, PhD Merck & Co., Inc.

Dr. Philip Kuhl, earned his B.S. in Engineering from The Cooper Union and PhD from MIT. He started his career with Merck in 1997 in small molecule process development and pilot plant scale up. Thereafter he transitioned to large molecules, where he served as a design engineer, FAT, commissioning and qualification lead for a new drug substance facility, and then moved into start up lead and finally Integrated Process Team (Manufacturing Operations) lead for that facility. He has led technology transfer projects in the U.S., Singapore, Puerto Rico, and Ireland for both small and large molecule drug substances. Today, he leads a late stage process development, characterization and technology transfer group for candidate vaccines; he specializes in vaccine drug substance processes involving chemical reaction steps.

Philip received an Executive MBA from Wharton in 2011 and served as a Merck Fellow for Global Health in 2014 at Bayalpata Hospital, Nepal, where he led a supply chain redesign effort for Possible, an NGO dedicated to providing free health care to the underserved of Achham province.